Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study

Código QR

Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study

Guardado en:

Detalles Bibliográficos
Autores principales:	Yoshihiro Inoue, Yusuke Suzuki, Keisuke Yokohama, Hideko Ohama, Yusuke Tsuchimoto, Akira Asai, Shinya Fukunishi, Fumiharu Kimura, Kazuhide Higuchi, Kazuhisa Uchiyama
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	diabetes mellitus hepatocellular carcinoma hepatic resection Medicine R
Acceso en línea:	https://doaj.org/article/d941fd5228394db684798ebcce0d112f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hepatectomy and liver regeneration in the results of treatment of colorectal liver metastasis
por: Yoshihiro Inoue, et al.
Publicado: (2020)

Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis
por: Xinyu Chen, et al.
Publicado: (2021)

An approach to grossing of hepatectomy specimens
por: Archana Rastogi
Publicado: (2021)

Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus‐related hepatocellular carcinoma after surgical resection: A multicenter study
por: Weili Qi, et al.
Publicado: (2021)

Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis
por: Zhijun Li, et al.
Publicado: (2021)

Laparoscopic versus open major liver resection for hepatocellular carcinoma: A case-matched analysis of short- and long-term outcomes
por: He Aoxiao, et al.
Publicado: (2021)

Primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy: a case report
por: Yusuke Seki, et al.
Publicado: (2021)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Toofan Datfar, et al.
Publicado: (2021)

Enhanced Recovery After Surgery in Patients With Hepatocellular Carcinoma Undergoing Laparoscopic Hepatectomy
por: Jiamin Zhou, et al.
Publicado: (2021)

Association Between Procalcitonin and Post-hepatectomy Liver Failure in Hepatocellular Carcinoma Patients
por: Yi-Ran Li, et al.
Publicado: (2021)

Influence of critical hypotension on the development of postoperative hepatic failure
por: N. G. Kornilov, et al.
Publicado: (2013)

Combination of three-dimensional reconstruction technique and blood parameters for the evaluation of tumor burden and prognosis in patients with hepatocellular carcinoma undergoing liver resection
por: Bibesh Pokhrel, et al.
Publicado: (2020)

Surgical Alternatives Used in the Treatment of Liver Hydatid Cyst: A Systematized Approach Based on Evidence (an Overview)
por: Manterola,Carlos, et al.
Publicado: (2016)

Hepatocarcinoma, porfiria y hemosiderosis. Una asociación no reportada en nuestro país: Caso clínico
por: WHITTLE,CAROLINA, et al.
Publicado: (2010)

SHORT-TERM RESULTS OF SIMULTANEOUS SURGERIES AT METASTATIC COLORECTAL CANCER
por: A. S. Zagaynov, et al.
Publicado: (2017)

Hepatocarcinoma.: Descripción de características clínicas verificadas en una Región del sur de Chile
por: Manterola D,Carlos, et al.
Publicado: (2000)

The Significance of Circulating Cell-Free DNA Markers in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
por: Alkistis Papatheodoridi, et al.
Publicado: (2021)

HEPATOCELLULAR CARCINOMA AT INITIAL PRESENTATION AND ITS SUBSEQUENT THERAPEUTIC OPTIONS OFFERED: A TERTIARY CARE HOSPITAL EXPERIENCE
por: Asim Shehzad, et al.
Publicado: (2019)

Prognostic Influence of Spontaneous Tumor Rupture in Patients With Hepatocellular Carcinoma After Hepatectomy: A Meta-Analysis of Observational Studies
por: Jiaxuan Xu, et al.
Publicado: (2021)

Prognostic Value of the Preoperative Lymphocyte-C-Reactive Protein Ratio in Hepatocellular Carcinoma Patients Treated with Curative Intent: A Large-Scale Multicentre Study
por: Zhang YF, et al.
Publicado: (2021)

Combination of chemoembolization with hepatic resection and methods of local destruction in complex treatment of colorectal cancer
por: A. S. Zagainov, et al.
Publicado: (2017)

GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial–mesenchymal transition of hepatic stellate cells
por: Niu Gengming, et al.
Publicado: (2021)

Combining Preoperative and Postoperative Inflammatory Indicators Can Better Predict the Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy
por: Wu M, et al.
Publicado: (2021)

CHANGES OF BLOOD CYTOKINE LEVELS IN THE COURSE OF DEVELOPING LIVER INSUFFICIENCY AFTER HEPATIC SURGERY
por: A. N. Plekhanov, et al.
Publicado: (2014)

Hepatitis B Virus Promotes Hepatocellular Carcinoma Progression Synergistically With Hepatic Stellate Cells via Facilitating the Expression and Secretion of ENPP2
por: Wanyu Deng, et al.
Publicado: (2021)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista D, et al.
Publicado: (2021)

Diagnosis and Treatment of an Undifferentiated Embryonal Sarcoma of the Liver in a 37-Week Pregnant Woman: A Case Report
por: Hung TM, et al.
Publicado: (2021)

Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma
por: Mara Klöhn, et al.
Publicado: (2021)

Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin
por: Ng KJ, et al.
Publicado: (2016)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Masahiro Matsui, et al.
Publicado: (2021)

A case of pancreaticoduodenectomy and partial hepatic resection as repeat cytoreductive surgery for recurrent pseudomyxoma peritonei
por: Kenya Yamanaka, et al.
Publicado: (2021)

Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
por: Yuki Zaizen, et al.
Publicado: (2021)

Regression of tumor thrombus in the suprahepatic vena cava of hepatocellular carcinoma and conversion hepatectomy induced by lenvatinib
por: Ryota Matsuki, et al.
Publicado: (2021)

Comprehensive Identification of Bridge Genes to Explain the Progression from Chronic Hepatitis B Virus Infection to Hepatocellular Carcinoma
por: Nong W, et al.
Publicado: (2021)

NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
por: Wang Jianlong, et al.
Publicado: (2021)

AUDIT OF LIVER RESECTIONS IN ARMY LIVER TRANSPLANT UNIT
por: Ammad Ud Din Nasir, et al.
Publicado: (2019)

Extra-articular resection of the hip joint for pelvic sarcomas: Are there any oncological and functional risks compared with intra-articular resection?
por: Tomohiro Fujiwara, et al.
Publicado: (2021)

Silicon Nanowire Field-Effect Transistor as Label-Free Detection of Hepatitis B Virus Proteins with Opposite Net Charges
por: Suh Kuan Yong, et al.
Publicado: (2021)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
por: L. V. Bolotina
Publicado: (2020)

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Liming Zheng, et al.
Publicado: (2021)